David Smith | Head of Innovation and Engineering
Hitachi Chemical Advanced Therapeutics Solutions, LLC

David Smith, Head of Innovation and Engineering, Hitachi Chemical Advanced Therapeutics Solutions, LLC

Appearances:



Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 11:40

Plenary Round Table Discussion Session: Process Development & Manufacturing Focus

Table 4. The future of cell therapy manufacturing technologies: All-in-one platforms or unit operation-specific devices?

Advanced Therapies and Regenerative Medicine Day 2 - Thursday 17th May 2018 @ 12:20

Maintaining quality with a robust supply chain; a thought to media decisions

  • Robust data set around cGMP media for sustainable production of cell therapy products
  • Streamlined development pathway with Development-by-Design (DbD) through a robust line of key raw material qualifications
  • Case study that maximizes mesenchymal stem cell (MSC) yield with a directly scalable culture method

back to speakers

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com